Insight into the formation of N-nitrosodimethylamine in metformin products
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 195, 113877
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography–tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2020
- NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosaminesJournal of Pharmaceutical and Biomedical Analysis, 2019
- Thresholds of Genotoxic and Non-Genotoxic CarcinogensToxicological Research, 2018
- Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity testsMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2016
- Dietary Nitrates, Nitrites, and Nitrosamines Intake and the Risk of Gastric Cancer: A Meta-AnalysisNutrients, 2015
- Reactive Impurities in Excipients: Profiling, Identification and Mitigation of Drug–Excipient IncompatibilityAAPS PharmSciTech, 2011
- Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approachMutation Research - Reviews in Mutation Research, 2009
- Lifestyle-related factors and environmental agents causing cancer: An overviewBiomedicine & Pharmacotherapy, 2007
- 3.7. Genotoxicity and MutagenicityAlternatives to Laboratory Animals, 2005
- Linearity of calibration curves: use and misuse of the correlation coefficientAccreditation and Quality Assurance, 2002